Literature DB >> 6274309

Characterization of the phosphorylated form of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.

R J Marchmont, M D Houslay.   

Abstract

Incubation of intact purified rat liver plasma membranes with insulin, cyclic AMP and ATP led to the activation of the peripheral "low-Km" cyclic AMP phosphodiesterase. When (gamma-32P]ATP was included in the incubation mixture, after purification of this enzyme to homogeneity it was found to contain 1 mol of alkali-labile 32P/mol of enzyme. Treatment of the homogeneous phosphorylated enzyme with alkaline phosphatase released all of the 32P from the protein while restoring its activity to the native state. The reversibility of the activation that is achieved by the phosphorylation of this enzyme could also be demonstrated with a high-speed supernatant from rat liver. This restored the activity of the activated membrane-bound enzyme to its native state. The Ka for the cyclic AMP-dependence of this process (1.6 micrometer) was unaffected by a range of ATP concentrations (1-10 mM) and by a range of membrane protein concentrations (0.2-2 mg/ml). Adenylyl imidodiphosphate could not substitute for ATP, and concanavalin A could not substitute for insulin, as essential ligands in the activation process. The purified activated enzyme exhibited Km 0.6 microM, Vmax 10.9 units/mg of protein and Hill coefficient (h) 0.47. The Vmax. for this activated enzyme was much higher than that of the native enzyme, yet h was much lower.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274309      PMCID: PMC1162937          DOI: 10.1042/bj1950653

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  A micro biuret method for protein determination; determination of total protein in cerebrospinal fluid.

Authors:  J GOA
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

2.  Isolation of a plasma-membrane subfraction from rat liver containing an insulin-sensitive cyclic-AMP phosphodiesterase.

Authors:  P D House; P Poulis; M J Weidemann
Journal:  Eur J Biochem       Date:  1972-01-21

3.  Multiple cyclic nucleotide phosphodiesterase activities from rat brain.

Authors:  W J Thompson; M M Appleman
Journal:  Biochemistry       Date:  1971-01-19       Impact factor: 3.162

4.  Role of adenosine 3',5'-monophosphate in the effects of insulin and anti-insulin serum on liver metabolism.

Authors:  L S Jefferson; J H Exton; R W Butcher; E W Sutherland; C R Park
Journal:  J Biol Chem       Date:  1968-03-10       Impact factor: 5.157

5.  A simple method for the preparation of 32-P-labelled adenosine triphosphate of high specific activity.

Authors:  I M Glynn; J B Chappell
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

6.  Proteolytic solubilization and modification of hormone-sensitive cyclic nucleotide phosphodiesterase.

Authors:  E G Loten; S H Francis; J D Corbin
Journal:  J Biol Chem       Date:  1980-08-25       Impact factor: 5.157

7.  A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes.

Authors:  R J Marchmont; M D Houslay
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

8.  Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents.

Authors:  H Makino; P M de Buschiazzo; R H Pointer; J E Jordan; T Kono
Journal:  J Biol Chem       Date:  1980-08-25       Impact factor: 5.157

9.  Role of intracellular energy in insulin's ability to activate 3-O-methylglucose transport by rat adipocytes.

Authors:  J Siegel; J M Olefsky
Journal:  Biochemistry       Date:  1980-05-13       Impact factor: 3.162

10.  Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator.

Authors:  J R Seals; M P Czech
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

View more
  18 in total

1.  Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.

Authors:  Y Shakur; J G Pryde; M D Houslay
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

2.  Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the rat.

Authors:  N J Pyne; N Anderson; B E Lavan; G Milligan; H G Nimmo; M D Houslay
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

3.  cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity.

Authors:  P G Grant; A F Mannarino; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  The insulin-stimulated cyclic AMP phosphodiesterase binds to a single class of protein sites on the liver plasma membrane.

Authors:  M D Houslay; R J Marchmont
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

5.  Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.

Authors:  R J Marchmont; S R Ayad; M D Houslay
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

Review 6.  A partial view of the mechanism of insulin action.

Authors:  R M Denton; R W Brownsey; G J Belsham
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

7.  Submitochondrial localization and asymmetric disposition of two peripheral cyclic nucleotide phosphodiesterases.

Authors:  B Cercek; M D Houslay
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

8.  Simulations of the roles of multiple cyclic nucleotide phosphodiesterases.

Authors:  C H Reynolds
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

9.  N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.

Authors:  A V Wallace; C M Heyworth; M D Houslay
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

10.  An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations.

Authors:  C M Heyworth; A V Wallace; S R Wilson; M D Houslay
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.